Evidence map›Paper›PMID 27055270›Full record

ArticlePloS one2016

Spontaneous Differentiation of Human Mesenchymal Stem Cells on Poly-Lactic-Co-Glycolic Acid Nano-Fiber Scaffold.

Koshiro Sonomoto, Kunihiro Yamaoka, Hiroaki Kaneko, Kaoru Yamagata, Kei Sakata, Xiangmei Zhang, Masahiro Kondo, Yukichi Zenke, Ken Sabanai, Shingo Nakayamada and 2 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. The Application of Biomaterials in Spinal Cord Injury.International journal of molecular sciences · 2023
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Koshiro SonomotoThe First department of internal medicine, school of medicine, University of occupational and environmental health, Kitakyushu, Fukuoka, Japan.
Kunihiro YamaokaThe First department of internal medicine, school of medicine, University of occupational and environmental health, Kitakyushu, Fukuoka, Japan.
Hiroaki KanekoIntegrative technology research institute, Teijin Limited, Hino, Tokyo, Japan.
Kaoru YamagataThe First department of internal medicine, school of medicine, University of occupational and environmental health, Kitakyushu, Fukuoka, Japan.
Kei SakataThe First department of internal medicine, school of medicine, University of occupational and environmental health, Kitakyushu, Fukuoka, Japan.
Xiangmei ZhangThe First department of internal medicine, school of medicine, University of occupational and environmental health, Kitakyushu, Fukuoka, Japan.
Masahiro KondoThe First department of internal medicine, school of medicine, University of occupational and environmental health, Kitakyushu, Fukuoka, Japan.
Yukichi ZenkeDepartment of orthopedics, school of medicine, University of occupational and environmental health, Kitakyushu, Fukuoka, Japan.
Ken SabanaiDepartment of orthopedics, school of medicine, University of occupational and environmental health, Kitakyushu, Fukuoka, Japan.
Shingo NakayamadaThe First department of internal medicine, school of medicine, University of occupational and environmental health, Kitakyushu, Fukuoka, Japan.
Akinori SakaiDepartment of orthopedics, school of medicine, University of occupational and environmental health, Kitakyushu, Fukuoka, Japan.
Yoshiya TanakaThe First department of internal medicine, school of medicine, University of occupational and environmental health, Kitakyushu, Fukuoka, Japan.
University of Occupational and Environmental Health Japan · JPKeio University · JPMitsubishi Tanabe Pharma CorporationTeijin (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMesenchymal stem cells (MSCs) have immunosuppressive activity and can differentiate into bone and cartilage; and thus seem ideal for treatment of rheumatoid arthritis (RA). Here, we investigated the osteogenesis and chondrogenesis potentials of MSCs seeded onto nano-fiber scaffolds (NFs) in vitro and possible use for the repair of RA-affected joints.

methodsMSCs derived from healthy donors and patients with RA or osteoarthritis (OA) were seeded on poly-lactic-glycolic acid (PLGA) electrospun NFs and cultured in vitro.

resultsHealthy donor-derived MSCs seeded onto NFs stained positive with von Kossa at Day 14 post-stimulation for osteoblast differentiation. Similarly, MSCs stained positive with Safranin O at Day 14 post-stimulation for chondrocyte differentiation. Surprisingly, even cultured without any stimulation, MSCs expressed RUNX2 and SOX9 (master regulators of bone and cartilage differentiation) at Day 7. Moreover, MSCs stained positive for osteocalcin, a bone marker, and simultaneously also with Safranin O at Day 14. On Day 28, the cell morphology changed from a spindle-like to an osteocyte-like appearance with processes, along with the expression of dentin matrix protein-1 (DMP-1) and matrix extracellular phosphoglycoprotein (MEPE), suggesting possible differentiation of MSCs into osteocytes. Calcification was observed on Day 56. Expression of osteoblast and chondrocyte differentiation markers was also noted in MSCs derived from RA or OA patients seeded on NFs. Lactic acid present in NFs potentially induced MSC differentiation into osteoblasts.

conclusionsOur PLGA scaffold NFs induced MSC differentiation into bone and cartilage. NFs induction process resembled the procedure of endochondral ossification. This finding indicates that the combination of MSCs and NFs is a promising therapeutic technique for the repair of RA or OA joints affected by bone and cartilage destruction.

Indexed as

Cell DifferentiationTissue ScaffoldsArthritis, RheumatoidBiocompatible MaterialsBlotting, WesternCase-Control StudiesCell ProliferationCells, CulturedChondrocytesChondrogenesisFlow CytometryHumansLactic AcidMesenchymal Stem CellsNanofibersOsteoarthritisBiocompatible MaterialsLactic AcidPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerRNA, Messenger

Identifiers

PMID27055270
PMCPMC4824423
OpenAlexW2335377813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.